Dapagliflozin (DAPA): clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Dapagliflozin (DAPA)

• A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
  NCT07082114 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Impact of Dapagliflozin in Anemic Chronic Kidney Disease Patients
  NCT06897605 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes
  NCT07614230 · Phase: Phase 4 · Ages: 18 Years to 78 Years · Sex: All (male and female) · 2 locations
• The Effect of Dapagliflozin on Patients With Cardiomyopathy
  NCT07076615 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Dapagliflozin (DAPA)?

4 recruiting trials across 9 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.